Table 1.
Clinical characteristics of patients in TCGA-LAML dataset.
| Discrete variables | Number | Percentage (%) |
|---|---|---|
| Gender | ||
| Male | 78 | 54.55 |
| Female | 65 | 45.45 |
| FAB subtype | ||
| M0 | 15 | 10.49 |
| M1 | 36 | 25.17 |
| M2 | 35 | 24.48 |
| M4 | 34 | 23.78 |
| M5 | 18 | 12.59 |
| M6 | 2 | 1.4 |
| M7 | 3 | 2.1 |
| Karyotype | ||
| Favorable | 17 | 11.89 |
| Intermediate | 94 | 65.73 |
| Poor | 30 | 20.98 |
| Unknown | 2 | 1.4 |
| Living status | ||
| Dead | 97 | 67.83 |
| Alive | 46 | 32.17 |
| IDH mutation | ||
| Positive | 27 | 18.88 |
| Negative | 114 | 79.72 |
| Unknown | 2 | 1.4 |
| FLT3 mutation | ||
| Positive | 35 | 24.48 |
| Negative | 101 | 70.63 |
| Unknown | 7 | 4.9 |
| RAS mutation | ||
| Positive | 8 | 5.59 |
| Negative | 132 | 92.31 |
| Unknown | 3 | 2.1 |
| NPM1 mutation | ||
| Positive | 42 | 29.37 |
| Negative | 98 | 68.53 |
| Unknown | 3 | |
| Continuous Variables | Range | Median |
| Age (years) | 18–88 | 60 |
| Overall survival (days) | 0–2861 | 334 |
| WBC (10^9/L) | 1–297 | 18 |